Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations

The physiologically based pharmacokinetic (PBPK) approach facilitates the construction of novel drug–disease models by allowing incorporation of relevant pathophysiological changes. The aim of the present work was to explore and identify the differences in rifampicin pharmacokinetics (PK) after the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmaceutics
Autori principali: Rasool, Muhammad F., Khalid, Sundus, Majeed, Abdul, Saeed, Hamid, Imran, Imran, Mohany, Mohamed, Al-Rejaie, Salim S., Alqahtani, Faleh
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6921057/
https://ncbi.nlm.nih.gov/pubmed/31694244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110578
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi